{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:58:56Z","timestamp":1772150336190,"version":"3.50.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":1680,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pulmonary fibrosis is a chronic and generally fatal disorder characterized by progressive formation of scar-like tissue in the lungs. Sialic acids are often found as the terminal sugar on extracellular glycoconjugates such as protein glycosylations. Sialidases, also known as neuraminidases, desialylate glycoconjugates. Serum amyloid P (SAP), a pentameric serum glycoprotein that has two sialic acids on each polypeptide, inhibits the differentiation of monocytes into fibrocytes and promotes human PBMCs to accumulate high extracellular levels of IL-10. When SAP is desialylated with sialidase, the effects of SAP on fibrocyte differentiation and IL-10 accumulation are strongly inhibited. Intriguingly, in patients with pulmonary fibrosis, there are increased levels of sialidase activity in the bronchoalveolar lavage fluid, increased levels of sialidases in the lungs, and decreased levels of SAP in the sera. To elucidate the role of SAP desialylation in idiopathic pulmonary fibrosis (IPF) pathogenesis, we purified SAP from the serum of IPF patients and healthy controls and measured the extent of sialylation and bioactivity of the purified SAP. We find that some IPF patients have abnormally high levels of the sialidase NEU3 in their sera and that the SAP in the sera of IPF patients has an abnormally high extent of desialylation and an abnormally low ability to inhibit fibrocyte differentiation and induce extracellular IL-10 accumulation by PBMC. These results suggest that SAP desialylation may play a role in IPF pathogenesis and that inhibiting NEU3 could be a potential therapeutic target for IPF.<\/jats:p>","DOI":"10.4049\/immunohorizons.2000043","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T19:45:14Z","timestamp":1592941514000},"page":"352-362","source":"Crossref","is-referenced-by-count":13,"title":["Reduced Sialylation and Bioactivity of the Antifibrotic Protein Serum Amyloid P in the Sera of Patients with Idiopathic Pulmonary Fibrosis"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2853-8422","authenticated-orcid":false,"given":"Wensheng","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Biology, Texas A&M University , College Station, TX 77843"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9241-8003","authenticated-orcid":false,"given":"Tejas R","family":"Karhadkar","sequence":"additional","affiliation":[{"name":"Department of Biology, Texas A&M University , College Station, TX 77843"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6211-4327","authenticated-orcid":false,"given":"Changwan","family":"Ryu","sequence":"additional","affiliation":[{"name":"Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine , New Haven, CT 06510"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica L","family":"Herzog","sequence":"additional","affiliation":[{"name":"Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine , New Haven, CT 06510"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard H","family":"Gomer","sequence":"additional","affiliation":[{"name":"Department of Biology, Texas A&M University , College Station, TX 77843"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,6,24]]},"reference":[{"key":"2025010608422449100_r1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev-pathol-020712-163930","article-title":"Host responses in tissue repair and fibrosis","volume":"8","author":"Duffield","year":"2013","journal-title":"Annu. Rev. Pathol."},{"key":"2025010608422449100_r2","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"King","year":"2011","journal-title":"Lancet"},{"key":"2025010608422449100_r3","doi-asserted-by":"crossref","first-page":"17093","DOI":"10.1074\/jbc.M116.731117","article-title":"Sialic acid within the glycosylphosphatidylinositol anchor targets the cellular prion protein to synapses","volume":"291","author":"Bate","year":"2016","journal-title":"J. Biol. Chem."},{"key":"2025010608422449100_r4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/imr.12344","article-title":"Sialic acids and autoimmune disease","volume":"269","author":"Mahajan","year":"2016","journal-title":"Immunol. Rev."},{"key":"2025010608422449100_r5","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.4049\/jimmunol.171.10.5537","article-title":"Inhibition of fibrocyte differentiation by serum amyloid P","volume":"171","author":"Pilling","year":"2003","journal-title":"J. Immunol."},{"key":"2025010608422449100_r6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jim.2009.09.011","article-title":"Improved serum-free culture conditions for the differentiation of human and murine fibrocytes","volume":"351","author":"Pilling","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"2025010608422449100_r7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.biocel.2010.10.013","article-title":"TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P","volume":"43","author":"Murray","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2025010608422449100_r8","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.4049\/jimmunol.1002315","article-title":"Macrophage differentiation and polarization via phosphatidylinositol 3-kinase\/Akt-ERK signaling pathway conferred by serum amyloid P component","volume":"187","author":"Zhang","year":"2011","journal-title":"J. Immunol."},{"key":"2025010608422449100_r9","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1001\/jama.2018.6129","article-title":"Effect of recombinant human pentraxin 2 vs placebo on change in forced vital capacity in patients with idiopathic pulmonary fibrosis: a randomized clinical trial","volume":"319","author":"Raghu","year":"2018","journal-title":"JAMA"},{"key":"2025010608422449100_r10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S2213-2600(19)30172-9","article-title":"Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study","volume":"7","author":"Raghu","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"2025010608422449100_r11","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.4049\/jimmunol.179.6.4035","article-title":"Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P","volume":"179","author":"Pilling","year":"2007","journal-title":"J. Immunol."},{"key":"2025010608422449100_r12","doi-asserted-by":"crossref","first-page":"18284","DOI":"10.1073\/pnas.0608799103","article-title":"Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice","volume":"103","author":"Haudek","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025010608422449100_r13","doi-asserted-by":"crossref","first-page":"8385","DOI":"10.1073\/pnas.1500956112","article-title":"DC-SIGN activation mediates the differential effects of SAP and CRP on the innate immune system and inhibits fibrosis in mice","volume":"112","author":"Cox","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025010608422449100_r14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0014-5793(95)00845-Z","article-title":"Effect of enzymatic desialylation of human serum amyloid P component on surface exposure of laser photo CIDNP (chemically induced dynamic nuclear polarization)--reactive histidine, tryptophan and tyrosine residues","volume":"371","author":"Siebert","year":"1995","journal-title":"FEBS Lett."},{"key":"2025010608422449100_r15","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1073\/pnas.91.12.5602","article-title":"Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure","volume":"91","author":"Pepys","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025010608422449100_r16","doi-asserted-by":"crossref","first-page":"L940","DOI":"10.1152\/ajplung.00346.2015","article-title":"Elevated expression of NEU1 sialidase in idiopathic pulmonary fibrosis provokes pulmonary collagen deposition, lymphocytosis, and fibrosis","volume":"310","author":"Luzina","year":"2016","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"2025010608422449100_r17","first-page":"230","article-title":"Sialidase activity and antibodies to sialidase-treated autologous erythrocytes in bronchoalveolar lavages from patients with idiopathic pulmonary fibrosis or sarcoidosis","volume":"73","author":"Lambr\u00e9","year":"1988","journal-title":"Clin. Exp. Immunol."},{"key":"2025010608422449100_r18","doi-asserted-by":"crossref","first-page":"15069","DOI":"10.1038\/s41598-017-15198-8","article-title":"Sialidase inhibitors attenuate pulmonary fibrosis in a mouse model","volume":"7","author":"Karhadkar","year":"2017","journal-title":"Sci. Rep."},{"key":"2025010608422449100_r19","doi-asserted-by":"crossref","first-page":"L165","DOI":"10.1152\/ajplung.00275.2019","article-title":"Attenuated pulmonary fibrosis in sialidase-3 knockout (Neu3-\/-) mice","volume":"318","author":"Karhadkar","year":"2020","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"2025010608422449100_r20","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2025010608422449100_r21","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","article-title":"A multidimensional index and staging system for idiopathic pulmonary fibrosis","volume":"156","author":"Ley","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"2025010608422449100_r22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1164\/rccm.201311-1951OC","article-title":"All-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trials","volume":"189","author":"King","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2025010608422449100_r23","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","article-title":"An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease","volume":"185","author":"Meyer","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2025010608422449100_r24","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1470-8744.1989.tb00073.x","article-title":"Purification of human serum amyloid P component (SAP) by calcium affinity chromatography","volume":"11","author":"Mantovaara","year":"1989","journal-title":"Biotechnol. Appl. Biochem."},{"key":"2025010608422449100_r25","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1084\/jem.159.4.1058","article-title":"Binding specificity of serum amyloid P component for the pyruvate acetal of galactose","volume":"159","author":"Hind","year":"1984","journal-title":"J. Exp. Med."},{"key":"2025010608422449100_r26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1524-475X.2009.00482.x","article-title":"A serum amyloid P-binding hydrogel speeds healing of partial thickness wounds in pigs","volume":"17","author":"Gomer","year":"2009","journal-title":"Wound Repair Regen."},{"key":"2025010608422449100_r27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093730","article-title":"Persistent lung inflammation and fibrosis in serum amyloid P component (APCs-\/-) knockout mice","volume":"9","author":"Pilling","year":"2014","journal-title":"PLoS One"},{"key":"2025010608422449100_r28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0003-2697(81)90783-1","article-title":"Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity","volume":"117","author":"Morrissey","year":"1981","journal-title":"Anal. Biochem."},{"key":"2025010608422449100_r29","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1021\/acs.analchem.5b00140","article-title":"Bayesian deconvolution of mass and ion mobility spectra: from binary interactions to polydisperse ensembles","volume":"87","author":"Marty","year":"2015","journal-title":"Anal. Chem."},{"key":"2025010608422449100_r30","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.4049\/jimmunol.1400281","article-title":"Distinct Fc\u03b3 receptors mediate the effect of serum amyloid p on neutrophil adhesion and fibrocyte differentiation","volume":"193","author":"Cox","year":"2014","journal-title":"J. Immunol."},{"key":"2025010608422449100_r31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.sbi.2009.06.003","article-title":"Sialic acids as regulators of molecular and cellular interactions","volume":"19","author":"Schauer","year":"2009","journal-title":"Curr. Opin. Struct. Biol."},{"key":"2025010608422449100_r32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2012.06517.x","article-title":"Multifarious roles of sialic acids in immunity","volume":"1253","author":"Varki","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2025010608422449100_r33","doi-asserted-by":"crossref","first-page":"11579","DOI":"10.1073\/pnas.1608383113","article-title":"Trisaccharide containing \u03b12,3-linked sialic acid is a receptor for mumps virus","volume":"113","author":"Kubota","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025010608422449100_r34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.yexcr.2013.10.017","article-title":"Sialic acid attenuates puromycin aminonucleoside-induced desialylation and oxidative stress in human podocytes","volume":"320","author":"Pawluczyk","year":"2014","journal-title":"Exp. Cell Res."},{"key":"2025010608422449100_r35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1189\/jlb.1105692","article-title":"Sialidase expression in activated human T lymphocytes influences production of IFN-\u03b3","volume":"81","author":"Nan","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"2025010608422449100_r36","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1074\/jbc.M116.764597","article-title":"Effects of altered sialic acid biosynthesis on N-linked glycan branching and cell surface interactions","volume":"292","author":"Pham","year":"2017","journal-title":"J. Biol. Chem."},{"key":"2025010608422449100_r37","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.3389\/fimmu.2018.02328","article-title":"The development of serum amyloid P as a possible therapeutic","volume":"9","author":"Pilling","year":"2018","journal-title":"Front. Immunol."},{"key":"2025010608422449100_r38","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.pupt.2013.01.008","article-title":"Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis","volume":"26","author":"Dillingh","year":"2013","journal-title":"Pulm. Pharmacol. Ther."},{"key":"2025010608422449100_r39","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1189\/jlb.1MR0114-068R","article-title":"Serum amyloid P: a systemic regulator of the innate immune response","volume":"96","author":"Cox","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"2025010608422449100_r40","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1084\/jem.20160283","article-title":"Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis","volume":"213","author":"Verstovsek","year":"2016","journal-title":"J. Exp. Med."},{"key":"2025010608422449100_r41","first-page":"391","article-title":"Serum amyloid P-component as a marker of liver involvement in measles infection","volume":"80","author":"Levo","year":"1985","journal-title":"Am. J. Gastroenterol."},{"key":"2025010608422449100_r42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jhep.2006.04.014","article-title":"Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis","volume":"45","author":"Kisseleva","year":"2006","journal-title":"J. Hepatol."},{"key":"2025010608422449100_r43","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s12265-015-9661-1","article-title":"Serum amyloid P-component prevents cardiac remodeling in hypertensive heart disease","volume":"8","author":"Horgan","year":"2015","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"2025010608422449100_r44","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/oxfordjournals.jbchem.a121797","article-title":"Isolation and characterization of the complete complementary and genomic DNA sequences of human serum amyloid P component","volume":"100","author":"Ohnishi","year":"1986","journal-title":"J. Biochem."},{"key":"2025010608422449100_r45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF03403533","article-title":"Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair","volume":"1","author":"Bucala","year":"1994","journal-title":"Mol. Med."},{"key":"2025010608422449100_r46","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nri2990","article-title":"Fibrocytes: emerging effector cells in chronic inflammation","volume":"11","author":"Reilkoff","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"2025010608422449100_r47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/BJ20070503","article-title":"Sialidase NEU3 is a peripheral membrane protein localized on the cell surface and in endosomal structures","volume":"408","author":"Zanchetti","year":"2007","journal-title":"Biochem. J."},{"key":"2025010608422449100_r48","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1134\/S0006297913070067","article-title":"Desialylation of surface receptors as a new dimension in cell signaling","volume":"78","author":"Pshezhetsky","year":"2013","journal-title":"Biochemistry (Mosc.)"},{"key":"2025010608422449100_r49","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10719-012-9394-1","article-title":"Sialidase significance for cancer progression","volume":"29","author":"Miyagi","year":"2012","journal-title":"Glycoconj. J."},{"key":"2025010608422449100_r50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/01902148.2020.1733135","article-title":"TGF-\u03b21 increases sialidase 3 expression in human lung epithelial cells by decreasing its degradation and upregulating its translation","volume":"46","author":"Chen","year":"2020","journal-title":"Exp. Lung Res."}],"container-title":["ImmunoHorizons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article-pdf\/4\/6\/352\/60186429\/ih2000043.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article-pdf\/4\/6\/352\/60186429\/ih2000043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T08:47:18Z","timestamp":1736153238000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article\/4\/6\/352\/7820546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.4049\/immunohorizons.2000043","relation":{},"ISSN":["2573-7732"],"issn-type":[{"value":"2573-7732","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6]]},"published":{"date-parts":[[2020,6,1]]}}}